The BET bromodomain inhibitor i-BET151 impairs ovarian cancer metastasis and improves antitumor immunity

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Jake Delmore, Ghayas C. Issa, Madeleine E. Lemieux et al. · Cell · 2011 · 2.8K citations · Full text

Medicine, Immunology, Therapeutic Efficacy +7

Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition

Alexandre Puissant, Stacey M. Frumm, Gabriela Alexe et al. · Cancer Discovery · 2013 · 624 citations · Full text

Neuro-oncology, Bromodomain Inhibition, Novel Therapy +14

Small-Molecule Inhibition of BRDT for Male Contraception

Martin M. Matzuk, Michael R. McKeown, P. Filippakopoulos et al. · Cell · 2012 · 410 citations · Full text

Spermatogenesis, Contraceptive Use, Testis Boundary +24

FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation

Jingshan Tong, Shuai Tan, Fangdong Zou et al. · Oncogene · 2016 · 167 citations · Full text

Systems Biology, Medicine, Colorectal Cancer +11

Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells

Jingshan Tong, Peng Wang, Shuai Tan et al. · Cancer Research · 2017 · 156 citations · Full text